Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Kaiser Daily Global Health Policy ReportHIV/AIDS Search Results « » The Henry J. Kaiser Family Foundation

HIV/AIDS

  • your selections
Clear Search

Filter Results

date

Tags

  • results
ART Associated With Reduced Risk Of HIV Transmission To Sexual Partners, Study Shows

Research published in the Lancet online Thursday “provides the strongest evidence to date” that antiretroviral therapy (ART) might also be used to prevent transmission of HIV, Agence France-Presse reports. The observational study found that treating HIV-positive patients with ART reduced the risk of HIV transmission to their sexual partners by 92 percent (5/26).

Also In Global Health News: WHO HIV/AIDS Treatment Guidelines In Malawi; U.S., Nigeria To Collaborate On HIV Vaccine Research; Water Scarcity

IRIN PlusNews Reports On Possible Effects Of Adopting WHO HIV/AIDS Treatment Guidelines In Malawi IRIN PlusNews examines the outcomes of a WHO-supported study in Malawi to assess what adopting the new WHO HIV/AIDS treatment guidelines would mean for the country. “According to the feasibility study, [adopting the guidelines would increase] the number…

KPBS Examines Microbicide Research As M2010 Concludes

KPBS reports on researchers’ efforts to develop novel methods to protect women from HIV infection that have been examined at the International Microbicides Conference (M2010) in Pittsburgh this week. In sub-Saharan Africa, one of the region’s hardest hit by HIV/AIDS, “six out of ten adults living with the virus are women,” KPBS writes. The piece names several factors that increase women’s vulnerability to HIV transmission in the region and the need “for protection [against HIV] that women can use discreetly,” such as microbicides.

Researchers Present More Findings For Microbicides, PrEP At M2010 Conference

Researchers on Monday at the International Microbicides Conference (M2010) in Pittsburgh continued to present data on HIV prevention research, Reuters reports. The news service outlines several prevention methods being researched, including an intravaginal ring that over time releases two antiretrovirals (ARVs) – dapivirine and maraviroc – for up to a month, and a vaginal tablet that time-releases the antiretrovirals dapivirine and DS003 for up to 12 hours. Both methods have yet to reach clinical trials.

G7 Aid Delivers ‘Impressive Results,’ Commitment Falls Short Of 2005 Pledge

According to an annual ONE report, which tracks progress on aid commitments made at the 2005 G8 summit in Gleneagles, Scotland, the G7 – Canada, France, Germany, Italy, Japan, the United Kingdom and the U.S. – is “on track to deliver 61 percent of their combined commitments to sub-Saharan Africa, or $13.7 billion of the $22.6 billion increase they promised,” allAfrica.com reports. The ONE report says that “there has been great progress in the past five years but … we have enough data to know that the [aid] targets and their ambitiously hopeful outcomes have not been met,” according to allAfrica.com (Allen, 5/25).